- Home
- About
- Find staff
- Peter Bernhardt
Peter Bernhardt
Professor/ Medical Physicist
Department of Medical Radiation Sciences-
Comparison of the tolerability of 161Tb- and 177Lu-labeled somatostatin analogues in the preclinical
setting
Sarah D. Busslinger, Ana Katrina Mapanao, Kristel Kegler, Peter Bernhardt, Fabienne Fluhmann, Julia Fricke, Jan Rijn Zeevaart, Ulli Koester, Nicholas P. van der Meulen, Roger Schibli, Cristina Mueller
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING - 2024 -
Relationship Between Absorbed Dose and Response in Neuroendocrine Tumors Treated with [ 177
Lu]Lu-DOTATATE
Carl Fredrik Warfvinge, Johan Gustafsson, Daniel Roth, Jan Tennvall, Johanna Svensson, Peter Bernhardt, Anna Akesson, Elinore Wieslander, Anna Sundlov, Katarina Sjogreen Gleisner
JOURNAL OF NUCLEAR MEDICINE - 2024 -
Improvements of 177Lu SPECT images from sparsely acquired projections by reconstruction with deep-learning-generated synthetic
projections
Emma Wikberg, Martijn van Essen, Tobias Ryden, Johanna Svensson, Peter Gjertsson, Peter Bernhardt
EJNMMI PHYSICS - 2024 -
Radiolabeled Somatostatin Receptor Antagonist Versus Agonist for Peptide Receptor Radionuclide Therapy in Patients with Therapy-Resistant Meningioma: PROMENADE Phase 0
Study
Christopher Eigler, Lisa McDougall, Andreas Bauman, Peter Bernhardt, Michael Hentschel, Kristine A. Blackham, Guillaume Nicolas, Melpomeni Fani, Damian Wild, Dominik Cordier
JOURNAL OF NUCLEAR MEDICINE - 2024 -
First-in-human administration of terbium-161-labelled somatostatin receptor subtype 2 antagonist ([161Tb]Tb-DOTA-LM3) in a patient with a metastatic neuroendocrine tumour of the
ileum
Julia Fricke, Frida Westerbergh, Lisa McDougall, Chiara Favaretto, Emanuel Christ, Guillaume P Nicolas, Susanne Geistlich, Francesca Borgna, Melpomeni Fani, Peter Bernhardt, Nicholas P van der Meulen, Cristina Müller, Roger Schibli, Damian Wild
European Journal of Nuclear Medicine and Molecular Imaging - 2024 -
Dosimetric implications of kidney anatomical volume changes in 177Lu-DOTATATE
therapy
Jehangir Khan, Tobias Ryden, Martijn Van Essen, Johanna Svensson, Joseph Grudzinski, Peter Bernhardt
EJNMMI PHYSICS - 2024 -
Deep Learning Denoising of 177Lu-PSMA Triple-Bed SPECT Using Clinical 68Ga PET/CT Images as Digital
Phantoms
Frida Westerbergh, Tobias Rydén, Martijn van Essen, Jon Kindblom, Peter Bernhardt
J Nucl Med, Vol 64, Suppl 1 (2023), P909 - 2023 -
Specific Uptake in the Bone Marrow Causes High Absorbed Red Marrow Doses During [177Lu]Lu-DOTATATE
Treatment.
Jens Hemmingsson, Johanna Svensson, Andreas Hallqvist, katja Smits, Viktor Johanson, Peter Bernhardt
Journal of nuclear medicine : official publication, Society of Nuclear Medicine - 2023 -
Demonstrating the Quantitative Potential of Terbium-161 SPECT/CT Imaging: An Anthropomorphic Phantom
Study
Frida Westerbergh, Nicholas van der Meulen, Cristina Müller, Andreas Grings, Philipp Ritt, Peter Bernhardt
Eur J Nucl Med Mol Imaging, Vol 50, Suppl 1 (2023), p. 38. - 2023 -
Albumin-Binding and Conventional PSMA Ligands in Combination with 161Tb: Biodistribution, Dosimetry, and Preclinical
Therapy
Viviane J. Tschan, Sarah D. Busslinger, Peter Bernhardt, Pascal V. Grundler, Jan Rijn Zeevaart, Ulli Koester, Nicholas P. van der Meulen, Roger Schibli, Cristina Mueller
JOURNAL OF NUCLEAR MEDICINE - 2023 -
Evaluation of reconstruction methods and image noise levels concerning visual assessment of simulated liver lesions in In-111-octreotide SPECT
imaging
Emma Wikberg, M. van Essen, T. Ryden, Johanna Svensson, Peter Gjertsson, Peter Bernhardt
EJNMMI Physics - 2023 -
Exploring the Quantitative Impact of Non-Uniformities in SPECT-Imaging With
(161)Tb
Frida Westerbergh, Tobias Rydén, Martijn van Essen, Nicholas van der Meulen, Cristina Müller, Peter Bernhardt
European Journal of Nuclear Medicine and Molecular Imaging (2022) 49 (Suppl 1): s.265-66 - 2022 -
Patient-Specific Kidney Recovery Coefficients May Increase Dosimetry Accuracy of (177)Lu-Radiopharmaceutical
Treatments
Frida Westerbergh, Tobias Rydén, Jehangir Khan, Martijn van Essen, Johanna Svensson, Joseph Grudzinski, Peter Bernhardt
Journal of Nuclear Medicine, June 2022; Volume 63, Issue Supplement 2 - 2022 -
Phase II trial demonstrates the efficacy and safety of individualized, dosimetry-based Lu-177-DOTATATE treatment of NET
patients
A. Sundlov, K. S. Gleisner, J. Tennvall, M. Ljungberg, C. F. Warfvinge, K. Holgersson, Andreas Hallqvist, Peter Bernhardt, Johanna Svensson
European Journal of Nuclear Medicine and Molecular Imaging - 2022 -
Preclinical investigations using Lu-177 Lu-lbu-DAB-PSMA toward its clinical translation for radioligand therapy of prostate
cancer
V. J. Tschan, F. Borgna, S. D. Busslinger, M. Stirn, J. M. M. Rodriguez, Peter Bernhardt, R. Schibli, C. Muller
European Journal of Nuclear Medicine and Molecular Imaging - 2022 -
Active bone marrow S-values for the low-energy electron emitter terbium-161 compared to S-values for lutetium-177 and
yttrium-90.
Jens Hemmingsson, Johanna Svensson, Nicholas P van der Meulen, Cristina Müller, Peter Bernhardt
EJNMMI physics - 2022 -
EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting
ligands
K. S. Gleisner, N. Chouin, P. M. Gabina, F. Cicone, S. Gnesin, C. Stokke, M. Konijnenberg, M. Cremonesi, F. A. Verburg, Peter Bernhardt, U. Eberlein, J. Gear
European Journal of Nuclear Medicine and Molecular Imaging - 2022 -
Dosimetric analysis of the short-ranged particle emitter161 tb for radionuclide therapy of metastatic prostate
cancer
Peter Bernhardt, Johanna Svensson, Jens Hemmingsson, N. P. van der Meulen, J. R. Zeevaart, M. W. Konijnenberg, C. Müller, Jon Kindblom
Cancers - 2021 -
Optimizing the Schedule of PARP Inhibitors in Combination with 177Lu-DOTATATE: A Dosimetry
Rationale.
Andreas Hallqvist, Johanna Svensson, Linn Hagmarker, Ida Marin, Tobias Rydén, Jean-Mathieu Beauregard, Peter Bernhardt
Biomedicines - 2021 -
Pituitary function after high-dose 177Lu-DOTATATE therapy and long-term
follow-up.
Anna Sundlöv, Katarina Sjögreen-Gleisner, Jan Tennvall, Ludvig Dahl, Johanna Svensson, Anna Åkesson, Peter Bernhardt, Ola Lindgren
Neuroendocrinology - 2021 -
Bone marrow dosimetry for terbium-161 reveals higher dependence on source distribution within the bone marrow cavities compared to
lutetium-177
Jens Hemmingsson, Johanna Svensson, N. P van der Meulen, C Müller, Peter Bernhardt
European journal of nuclear medicine and molecular imaging - 2021 -
Deep learning generation of synthetic intermediate projections improves 177 Lu SPECT images reconstructed with sparsely acquired
projections
Tobias Rydén, Martijn van Essen, Ida Marin, Johanna Svensson, Peter Bernhardt
Journal of Nuclear Medicine - 2021 -
Promising potential of Lu-177 Lu-DOTA-folate to enhance tumor response to immunotherapy-a preclinical study using a syngeneic breast cancer
model
P. Guzik, K. Siwowska, H. Y. Fang, S. Cohrs, Peter Bernhardt, R. Schibli, C. Muller
European Journal of Nuclear Medicine and Molecular Imaging - 2021 -
Evaluation of sstr2 expression in si-nets and relation to overall survival after
prrt
Anna-Karin Elf, Viktor Johanson, Ida Marin, Anders Bergström, Ola Nilsson, Johanna Svensson, Bo Wängberg, Peter Bernhardt, Erik Elias
Cancers - 2021 -
Mars — Education of Ethics and
Planetary
Processes
Maria Sundin, Peter Ekberg, Andreas Johnsson, Peter Bernhardt, Jonas Enger
Lunar and Planetary Science Conference 52 - 2021 -
EANM dosimetry committee series on standard operational procedures: a unified methodology for Tc-99m-MAA pre- and Y-90 peri-therapy dosimetry in liver radioembolization with Y-90
microspheres
C. Chiesa, K. Sjogreen-Gleisner, S. Walrand, L. Strigari, G. Flux, J. Gear, C. Stokke, P. M. Gabina, Peter Bernhardt, M. Konijnenberg
Ejnmmi Physics - 2021 -
IMPROVEMENTS OF (IN)-I-111 SPECT IMAGES RECONSTRUCTED WITH SPARSELY ACQUIRED PROJECTIONS BY DEEP LEARNING GENERATED SYNTHETIC
PROJECTIONS
T. Ryden, Emma Wikberg, M. Van Essen, J. Svensson, Peter Bernhardt
Radiation Protection Dosimetry - 2021 -
Artificial intelligence and the medical physics profession-A Swedish
perspective
J. Andersson, T. Nyholm, C. Ceberg, A. Almen, Peter Bernhardt, A. Fransson, L. E. Olsson
Physica Medica-European Journal of Medical Physics - 2021 -
Mars – a target for teachers and science
students
Maria Sundin, Peter Bernhardt, Peter Ekberg, Jonas Enger, Andreas Johnsson
Proceedings of the International Astronomical Union, Vol 15, Symposium 367S - 2021 -
Establishment of a clinical SPECT/CT protocol for imaging
of(161)Tb
Ida Marin, T. Ryden, M. Van Essen, J Svensson, N. Gracheva, U. Koster, J. R. Zeevaart, N. P. van Der Meulen, C. Muller, Peter Bernhardt
Ejnmmi Physics - 2020 -
Evaluation of Monte Carlo based reconstruction concerning visual assessment of simulated liver metastases in 111In-octreotide SPECT
imaging
Emma Wikberg, Martijn van Essen, Tobias Rydén, Johanna Svensson, Peter Gjertsson, Peter Bernhardt
33th Annual Congress of the European Association of Nuclear Medicine - 2020 -
Mars - a target for teachers and science
students
Maria Sundin, Peter Bernhardt, Peter Ekberg, Jonas Enger, Andreas Johnsson
Contribution to IAU 367S, Education and Heritage in the Era of Big Data in Astronomy, 8-12 December 2020. - 2020 -
Albumin-Binding PSMA Radioligands: Impact of Minimal Structural Changes on the Tissue Distribution
Profile
L. M. Deberle, V. J. Tschan, F. Borgna, F. Sozzi-Guo, Peter Bernhardt, R. Schibli, C. Muller
Molecules - 2020 -
Alpha-PET for Prostate Cancer: Preclinical investigation using
Tb-149-PSMA-617
C. A. Umbricht, U. Koster, Peter Bernhardt, N. Gracheva, K. Johnston, R. Schibli, N. P. van der Meulen, C. Muller
Scientific Reports - 2019 -
Terbium-161 for PSMA-targeted radionuclide therapy of prostate
cancer
C. Muller, C. A. Umbricht, N. Gracheva, V. J. Tschan, G. Pellegrini, Peter Bernhardt, J. R. Zeevaart, U. Koster, R. Schibli, N. P. van der Meulen
European Journal of Nuclear Medicine and Molecular Imaging - 2019 -
Combination of Proton Therapy and Radionuclide Therapy in Mice: Preclinical Pilot Study at the Paul Scherrer
Institute
C. Muller, M. D. Leal, M. D. Dominietto, C. A. Umbricht, S. Safai, R. L. Perrin, M. Egloff, Peter Bernhardt, N. P. van der Meulen, D. C. Weber, R. Schibli, A. J. Lomax
Pharmaceutics - 2019 -
Therapeutic Potential of Sc-47 in Comparison to Lu-177 and Y-90: Preclinical
Investigations
K. Siwowska, P. Guzik, K. A. Domnanich, J. M. M. Rodriguez, Peter Bernhardt, B. Ponsard, R. Hasler, F. Borgna, R. Schibli, U. Koster, N. P. van der Meulen, C. Muller
Pharmaceutics - 2019 -
Bone Marrow Absorbed Doses and Correlations with Hematologic Response During Lu-177-DOTATATE Treatments Are Influenced by Image-Based Dosimetry Method and Presence of Skeletal
Metastases
Linn Hagmarker, Johanna Svensson, Tobias Rydén, M. van Essen, A. Sundlov, K. S. Gleisner, P. Gjertsson, Peter Bernhardt
Journal of Nuclear Medicine - 2019 -
Feasibility of simplifying renal dosimetry in Lu-177 peptide receptor radionuclide
therapy
A. Sundlov, J. Gustafsson, G. Brolin, N. Mortensen, Rebecka Hermann, Peter Bernhardt, J. Svensson, M. Ljungberg, J. Tennvall, K. S. Gleisner
Ejnmmi Physics - 2018 -
Fast GPU-based Monte Carlo code for SPECT/CT reconstructions generates improved Lu-177
images
Tobias Rydén, Jakob Heydorn Lagerlöf, Jens Hemmingsson, Ida Marin, Johanna Svensson, Magnus Båth, P. Gjertsson, Peter Bernhardt
Ejnmmi Physics - 2018 -
Establishment of Optimized SPECT/CT Protocol for Therapy with 161Tb Demonstrate Improved Image Quality with Monte Carlo Based OSEM
Reconstruction
Ida Marin, Tobias Rydén, Martijn van Essen, Johanna Svensson, N. Van der Meulen, N. Gracheva, Christina Müller, Peter Bernhardt
31st Annual Congress of the European Association of Nuclear Medicine (EANM’18). 13-17 October, Dusseldorf, Germany - 2018 -
Evaluation of planar versus hybrid SPECT image methodology for bone marrow dosimetry during 177Lu-DOTATATE treatments reveals the obstacles with bone marrow metastases and cross-irradiation for the SPECT activity concentration
quantification
Linn Hagmarker, Johanna Svensson, Tobias Rydén, Martijn van Essen, Anna Sundlöv, Katarina Sjögreen Gleisner, Peter Gjertsson, Peter Bernhardt
31st Annual Congress of the European Association of Nuclear Medicine (EANM’18). 13-17 October, Dusseldorf, Germany - 2018 -
Autoradiography and biopsy measurements of a resected hepatocellular carcinoma treated with 90 yttrium radioembolization demonstrate large absorbed dose
heterogeneities
Jens Hemmingsson, Jonas Högberg, Johan Mölne, Johanna Svensson, Peter Gjertsson, Magnus Rizell, Olof Henrikson, Peter Bernhardt
Advances in Radiation Oncology - 2018 -
A Parallel Computation Approach to Detailed 3D Modelling of the Complete Oxygen Distribution in Large
Tumours
Jakob Heydorn Lagerlöf, Tobias Rydén, Peter Bernhardt
Cancer Studies and Therapeutics - 2018 -
Temporal Deformity Objectively Measured before and after Surgery for Metopic Synostosis: Retrusion Rather than
Hollowing
Madiha Bhatti Söfteland, Giovanni Maltese, Peter Tarnow, Linn Hagmarker, Emma Wikberg, Peter Bernhardt, Lars Kölby
Journal of Craniofacial Surgery - 2017 -
The Degree of Surgical Frontal Volume Correction in Metopic Synostosis Determines Long-Term
Outcomes
Madiha Bhatti Söfteland, Giovanni Maltese, Peter Tarnow, Emma Wikberg, Peter Bernhardt, Lars Kölby
Journal of Craniofacial Surgery - 2017 -
Preclinical Comparison of Albumin-Binding Radiofolates: Impact of Linker Entities on the in Vitro and in Vivo
Properties
K. Siwowska, S. Haller, F. Bortoli, M. Benesova, V. Groehn, Peter Bernhardt, R. Schibli, C. Muller
Molecular Pharmaceutics - 2017 -
Individualised Lu-177-DOTATATE treatment of neuroendocrine tumours based on kidney
dosimetry
A. Sundlov, K. Sjogreen-Gleisner, J. Svensson, M. Ljungberg, T. Olsson, Peter Bernhardt, J. Tennvall
European Journal of Nuclear Medicine and Molecular Imaging - 2017 -
NAMPT inhibitor GMX1778 enhances the efficacy of 177Lu-DOTATATE treatment of neuroendocrine
tumors.
Anna-Karin Elf, Peter Bernhardt, Tobias Hofving, Yvonne Arvidsson, Eva Forssell-Aronsson, Bo Wängberg, Ola Nilsson, Viktor Johanson
Journal of Nuclear Medicine - 2017 -
Comparison of a statistical analysis method and a visual assessment of Monte Carlo based SPECT reconstruction concerning liver metastases in 111In-octreotide
diagnosis.
Emma Wikberg, Martijn van Essen, Johanna Svensson, Peter Gjertsson, Peter Bernhardt
30th Annual Congress of the European Association of Nuclear Medicine - 2017 -
Monte Carlo Based SPECT Activity Quantification and Tumor Dosimetry for 177Lu-DOTATATE
Treatments
Ida Marin, Johanna Svensson, Tobias Rydén, Emma Wikberg, Anna-Karin Elf, Viktor Johanson, Peter Bernhardt
30th Annual Congress of the European Association of Nuclear Medicine - 2017 -
Autoradiography of a resected hepatocellular carcinoma treated with 90Y radioembolization illustrates uptake differences between viable and infarcted
areas
Jens Hemmingsson, Johan Mölne, Jonas Högberg, Johanna Svensson, Peter Gjertsson, Magnus Rizell, Olof Henrikson, Peter Bernhardt
European Journal of Nuclear Medicine and Molecular Imaging. 44 (Supplement 2), s. 802 (EP-0871) - 2017 -
Evaluation of the correlations between the absorbed bone marrow dose and bone marrow response during the first cycle of
177Lu-DOTATATE
treatment
Linn Hagmarker, Johanna Svensson, Tobias Magnander, Bo Wängberg, Peter Bernhardt
European Association of Nuclear Medicine - 2017 -
Segmentation of Whole-Body Images into Two Compartments in Model for Bone Marrow Dosimetry Increases the Correlation with Hematological Response in Lu-177-DOTATATE
Treatments
Linn Hagmarker, Johanna Svensson, Tobias Rydén, P. Gjertsson, Peter Bernhardt
Cancer Biotherapy and Radiopharmaceuticals - 2017 -
A novel planar image-based method for bone marrow dosimetry in (177)Lu-DOTATATE treatment correlates with haematological
toxicity.
Johanna Svensson, Tobias Rydén, Linn Hagmarker, Jens Hemmingsson, Bo Wängberg, Peter Bernhardt
EJNMMI Physics - 2016 -
Radiation exposure of the spleen during Lu-177-DOTATATE treatment and its correlation with haematological toxicity and spleen
volume
Johanna Svensson, Linn Hagmarker, Tobias Magnander, Bo Wängberg, Peter Bernhardt
Ejnmmi Physics - 2016 -
A new quantitative image-based method for evaluation of bony temporal hollowing in metopic
synostosis
Linn Hagmarker, Madiha Bhatti Söfteland, Giovanni Maltese, Peter Tarnow, Emma Wikberg, Lars Kölby, Peter Bernhardt
Journal of Plastic Surgery and Hand Surgery - 2016 -
IMPROVED PLANAR KIDNEY ACTIVITY CONCENTRATION ESTIMATE BY THE POSTERIOR VIEW METHOD IN 177LU-DOTATATE
TREATMENTS.
Tobias Magnander, Johanna Svensson, Magnus Båth, Peter Gjertsson, Peter Bernhardt
Radiation protection dosimetry - 2016 -
Comparison of Intracranial Volume and Cephalic Index After Correction of Sagittal Synostosis With Spring-assisted Surgery or
Pi-plasty.
Sara Fischer, Giovanni Maltese, Peter Tarnow, Emma Wikberg, Peter Bernhardt, Lars Kölby
The Journal of craniofacial surgery - 2016 -
Contribution of Auger/conversion electrons to renal side effects after radionuclide therapy: preclinical comparison of (161)Tb-folate and
(177)Lu-folate.
Stephanie Haller, Giovanni Pellegrini, Christiaan Vermeulen, Nicholas P van der Meulen, Ulli Köster, Peter Bernhardt, Roger Schibli, Cristina Müller
EJNMMI research - 2016 -
A novel statistical analysis method to improve the detection of hepatic foci of (111)In-octreotide in SPECT/CT
imaging.
Tobias Magnander, Emma Wikberg, Johanna Svensson, Peter Gjertsson, Bo Wängberg, Magnus Båth, Peter Bernhardt
EJNMMI physics - 2016 -
Image Fusion of Reconstructed Digital Tomosynthesis Volumes From a Frontal and a Lateral
Acquisition
Jonathan Arvidsson, Christina Söderman, Åse (Allansdotter) Johnsson, Peter Bernhardt, Göran Starck, Fredrik Kahl, Magnus Båth
Radiation protection dosimetry - 2016 -
Simulation of 90Y microspheres in selective internal radiation therapy (SIRT) reveals different heterogeneity profiles for glass and resin
microspheres.
Jens Hemmingsson, Jonas Högberg, Johanna Svensson, Johan Mölne, Magnus Rizell, Peter Bernhardt
European Journal of Nuclear Medicine and Molecular Imaging. 43 (Suppl 1): 1 - 2016 -
Characterisation of a planar dosimetry method estimating the absorbed dose to the bone marrow during 177Lu-DOTATATE
treatment
Linn Hagmarker, Johanna Svensson, Tobias Magnander, Jens Hemmingsson, Peter Gjertsson, Peter Bernhardt
European Journal of Nuclear Medicine and Molecular Imaging - 2016 -
A fast GPU code for full Monte Carlo based SPECT
reconstruction
Tobias Magnander, Jakob Heydorn Lagerlöf, Jens Hemmingsson, Magnus Båth, Johanna Svensson, Peter Gjertsson, Peter Bernhardt
European Journal of Nuclear Medicine and Molecular Imaging - 2016 -
Simulation Model of Microsphere Distribution for Selective Internal Radiation Therapy Agrees With
Observations
Jonas Högberg, M. Rizell, R. Hultborn, J. Svensson, O. Henrikson, J. Molne, Peter Gjertsson, Peter Bernhardt
International Journal of Radiation Oncology Biology Physics - 2016 -
Radiation exposure of the kidneys affects haematological response during 177Lu-DOTATATE
treatment
Johanna Svensson, Rebecka Hermann, Karin Holgersson, Bo Wängberg, A Sundlöv, G Tennvall, K Sjögren Gleisner, Peter Bernhardt
European Journal of Nuclear Medicine and Molecular Imaging - 2016 -
Oxygen Distributions-Evaluation of Computational Methods, Using a Stochastic Model for Large Tumour Vasculature, to Elucidate the Importance of Considering a Complete Vascular
Network.
Jakob Heydorn Lagerlöf, Peter Bernhardt
PloS one - 2016 -
Renal function affects absorbed dose to the kidneys and haematological toxicity during (177)Lu-DOTATATE
treatment.
Johanna Svensson, Gertrud Berg, Bo Wängberg, Maria Larsson, Eva Forssell-Aronsson, Peter Bernhardt
European Journal of Nuclear Medicine and Molecular Imaging - 2015 -
Increased absorbed liver dose in Selective Internal Radiation Therapy (SIRT) correlates with increased sphere-cluster frequency and absorbed dose
inhomogeneity
Jonas Högberg, Magnus Rizell, Ragnar Hultborn, Johanna Svensson, Olof Henrikson, Johan Mölne, Peter Gjertsson, Peter Bernhardt
EJNMMI Physics - 2015 -
Improved detection rate and visualization of liver uptake foci in diagnostic 111In-octreotide SPECT/CT investigations with a novel segmentation
analysis
Tobias Magnander, Emma Wikberg, Johanna Svensson, Peter Gjertsson, Bo Wängberg, Magnus Båth, Peter Bernhardt
Optimisation in X-ray and Molecular Imaging 2015 - the Fourth Malmö Conference on Medical Imaging, Gothenburg, Sweden, 28-30 May 2015 - 2015 -
Comparison of the accuracy in kidney activity concentration estimates by the conjugate view and posterior view
methods
Tobias Magnander, Johanna Svensson, Magnus Båth, Peter Gjertsson, Eva Forssell-Aronsson, Peter Bernhardt
Optimisation in X-ray and Molecular Imaging 2015 - the Fourth Malmö Conference on Medical Imaging, Gothenburg, Sweden, 28-30 May 2015 - 2015 -
Absorbed Doses and Risk Estimates of (211)At-MX35 F(ab')2 in Intraperitoneal Therapy of Ovarian Cancer
Patients.
Elin Cederkrantz, Håkan Andersson, Peter Bernhardt, Thomas Backhaus, Ragnar Hultborn, Lars Jacobsson, Holger Jensen, Sture Lindegren, Michael Ljungberg, Tobias Magnander, Stig Palm, Per Albertsson
International journal of radiation oncology, biology, physics - 2015 -
Folate receptor-targeted radionuclide therapy: preclinical investigation of anti-tumor effects and potential
radionephropathy.
Stephanie Haller, Josefine Reber, Simone Brandt, Peter Bernhardt, Viola Groehn, Roger Schibli, Cristina Müller
Nuclear medicine and biology - 2015 -
Intracranial volume is normal in infants with sagittal
synostosis.
Sara Fischer, Giovanni Maltese, Peter Tarnow, Emma Wikberg, Peter Bernhardt, Robert Tovetjärn, Lars Kölby
Journal of plastic surgery and hand surgery - 2015 -
Direct in vitro and in vivo comparison of (161)Tb and (177)Lu using a tumour-targeting folate
conjugate.
Cristina Müller, Josefine Reber, Stephanie Haller, Holger Dorrer, Peter Bernhardt, Konstantin Zhernosekov, Andreas Türler, Roger Schibli
European journal of nuclear medicine and molecular imaging - 2014 -
New objective measurement of forehead symmetry in unicoronal craniosynostosis - comparison between fronto-orbital advancement and forehead remodelling with a bone
graft.
Giovanni Maltese, Peter Tarnow, Annelie Lindström, Jakob Heydorn Lagerlöf, Peter Bernhardt, Robert Tovetjärn, Lars Kölby
Journal of plastic surgery and hand surgery - 2014 -
Automatic method for improved detection rate and visualization of liver uptake foci in diagnostic 111In-octreotide SPECT/CT
investigations
Tobias Magnander, Emma Wikberg, Jonas Nilsson, Johanna Svensson, Peter Gjertsson, Bo Wängberg, Magnus Båth, Peter Bernhardt
XI Congress of World Federation of Nuclear Medicine and Biology, 27-31 August 2014, Cancun, Mexico - 2014 -
Heterogeneity of microsphere distribution in resected liver and tumour tissue following selective intrahepatic
radiotherapy
Jonas Högberg, Magnus Rizell, Ragnar Hultborn, Johanna Svensson, Olof Henrikson, Johan Mölne, Peter Gjertsson, Peter Bernhardt
EJNMMI Research - 2014 -
Intracranial volume in 15 children with bilateral coronal
craniosynostosis.
Robert Tovetjärn, Giovanni Maltese, Emma Wikberg, Peter Bernhardt, Lars Kölby, Peter Tarnow
Plastic and reconstructive surgery. Global open - 2014 -
Oxygen distribution in tumors: A qualitative analysis and modeling study providing a novel Monte Carlo
approach
Jakob Heydorn Lagerlöf, Jon Kindblom, Peter Bernhardt
Medical Physics - 2014 -
Intracranial volume before and after surgical treatment for isolated metopic
synostosis.
Giovanni Maltese, Peter Tarnow, Emma Wikberg, Peter Bernhardt, Jakob Heydorn Lagerlöf, Robert Tovetjärn, Lars Kölby
The Journal of craniofacial surgery - 2014 -
Promising Prospects for Sc-44-/Sc-47-Based Theragnostics: Application of Sc-47 for Radionuclide Tumor Therapy in
Mice
C. Muller, M. Bunka, S. Haller, U. Koster, V. Groehn, Peter Bernhardt, N. van der Meulen, A. Turler, R. Schibli
Journal of Nuclear Medicine - 2014 -
The impact of including spatially longitudinal heterogeneities of vessel oxygen content and vascular fraction in 3D tumor oxygenation models on predicted radiation
sensitivity.
Jakob Heydorn Lagerlöf, Jon Kindblom, Peter Bernhardt
Medical physics - 2014 -
A multicentre phase II trial evaluating safety and efficacy of activity escalation with 177 Lu-DOTA_TATE in patients with disseminated neuroendocrine tumors, based on detailed dosimetry and patients
selection.
A Sundlöv, Johanna Svensson, K Sjögreen Gleisner, Peter Bernhardt, C Hindrof, M Garkavij, Bo Wängberg, T Ohlsson, Eva Forssell-Aronsson, J Tennvall
NANETS annual meeting, Charleston , USA, Okt, 4-6. - 2013 -
A new method to estimate parameters of the growth model for metastatic
tumours.
Esmaeil Mehrara, Eva Forssell-Aronsson, Viktor Johanson, Lars Kölby, Ragnar Hultborn, Peter Bernhardt
Theoretical biology & medical modelling - 2013 -
A novel quantitative image-based method for evaluating cranial symmetry and its usefulness in patients undergoing surgery for unicoronal
synostosis.
Peter Bernhardt, Annelie Lindström, Giovanni Maltese, Peter Tarnow, Jakob Heydorn Lagerlöf, Lars Kölby
The Journal of craniofacial surgery - 2013 -
Image-based 3D modeling study of the influence of vessel density and blood hemoglobin concentration on tumor oxygenation and response to
irradiation.
Jakob Heydorn Lagerlöf, Jon Kindblom, Eliane Cortez, Kristian Pietras, Peter Bernhardt
Medical physics - 2013 -
Radiation exposure during liver surgery after treatment with (90)Y microspheres, evaluated with computer simulations and dosimeter
measurements.
Jonas Högberg, Magnus Rizell, Ragnar Hultborn, Johanna Svensson, Olof Henrikson, Peter Gjertsson, Peter Bernhardt
Journal of radiological protection : official journal of the Society for Radiological Protection - 2012 -
On the dose heterogeneity in normal liver tissue due to treatment of liver tumors with yttrium-90
microspheres
Jonas Högberg, Magnus Rizell, Ragnar Hultborn, Johanna Svensson, Olof Henrikson, Peter Gjertsson, Peter Bernhardt
25th Annual Congress on European Association of Nuclear Medicine, Milano, Italy, October 27-31, 2012. European Journal of Nuclear Medicine and Molecular Imaging - 2012 -
A new computer tool for systematic evaluation of intracranial volume and its capacity to evaluate the result of the operation for metopic
synostosis.
Emma Wikberg, Peter Bernhardt, Giovanni Maltese, Peter Tarnow, Jakob Heydorn Lagerlöf, Lars Kölby
Journal of plastic surgery and hand surgery - 2012 -
Estimation of absorbed dose to the kidneys in patients after treatment with 177Lu-octreotate: comparison between methods based on planar
scintigraphy.
Maria Larsson, Peter Bernhardt, Johanna Svensson, Bo Wängberg, Håkan Ahlman, Eva Forssell-Aronsson
EJNMMI research - 2012 -
Nephrotoxicity profiles and threshold dose values for [(177)Lu]-DOTATATE in nude
mice.
Johanna Svensson, Johan Mölne, Eva Forssell-Aronsson, Mark Konijnenberg, Peter Bernhardt
Nuclear medicine and biology - 2012 -
Inhomogeneous activity distribution of (177)Lu-DOTA (0)-Tyr (3)-octreotate and effects on somatostatin receptor expression in human carcinoid GOT1 tumors in nude
mice.
Jenny Oddstig, Peter Bernhardt, Helena Lizana, Ola Nilsson, Håkan Ahlman, Lars Kölby, Eva Forssell-Aronsson
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine - 2012 -
Binding of TS1, an anti-keratin 8 antibody, in small cell lung cancer after 177Lu-DOTA-Tyr3-octreotate treatment: a histological study in xenografted
mice
Ann Erlandsson, Eva Forssell-Aronsson, Tomas Seidal, Peter Bernhardt
EJNMMI Research - 2011 -
Radiation Induces Up-Regulation of Somatostatin Receptors 1, 2, and 5 in Small Cell Lung Cancer In Vitro Also at Low Absorbed
Doses.
Jenny Oddstig, Peter Bernhardt, Ola Nilsson, Håkan Ahlman, Eva Forssell-Aronsson
Cancer biotherapy & radiopharmaceuticals - 2011 -
Absorbed dose to the kidneys after treatment with
177Lu-octreotate
Maria Larsson, Peter Bernhardt, Eva Forssell-Aronsson
European Journal of Nuclear Medicine & Molecular Imaging - 2011 -
3D modeling of effects of increased oxygenation and activity concentration in tumors treated with radionuclides and antiangiogenic
drugs.
Jakob Heydorn Lagerlöf, Jon Kindblom, Peter Bernhardt
Medical physics - 2011 -
Objective assessment of tumour response to therapy based on tumour growth
kinetics.
Esmaeil Mehrara, Eva Forssell-Aronsson, Peter Bernhardt
British journal of cancer - 2011 -
Absorbed dose to the kidneys after treatment with
177Lu-octreotate
Maria Larsson, Peter Bernhardt, Eva Forssell-Aronsson
European Association of Nuclear Medicine Congress. Birmingham - 2011 -
Assessment of tumour response to
therapy
Esmaeil Mehrara, Peter Bernhardt, Eva Forssell-Aronsson
European Association of Nuclear Medicine Congress. Birmingham - 2011 -
[(177)Lu-DOTA(0)-Tyr (3)]-Octreotate Treatment in Patients with Disseminated Gastroenteropancreatic Neuroendocrine Tumors: The Value of Measuring Absorbed Dose to the
Kidney.
Christina Swärd, Peter Bernhardt, Håkan Ahlman, Bo Wängberg, Eva Forssell-Aronsson, Maria Larsson, Johanna Svensson, Rauni Rossi-Norrlund, Lars Kölby
World journal of surgery - 2010 -
Bremsstrahlung imaging of 90Y microspheres shows poor resemblance with distributions of 99mTc-MAA in
liver
Jonas Högberg, Magnus Rizell, Peter Gjertsson, Ragnar Hultborn, Olof Henrikson, Johanna Svensson, Peter Bernhardt
Journal of the European Society of Therapeutic Radiology and Oncology - 2010 -
Modelling the systemic cure in radionuclide
therapy.
Peter Bernhardt, Speer
Targeted radionuclide therapy.Speer T (Eds) - 2010 -
Exendin-4-Based Radiopharmaceuticals for Glucagonlike Peptide-1 Receptor PET/CT and
SPECT/CT
Damian Wild, Andreas Wicki, Rosalba Mansi, Martin Behe, Boris Keil, Peter Bernhardt, Gerhard Christofori, Peter J. Ell, Helmut R. Maecke
JOURNAL OF NUCLEAR MEDICINE - 2010 -
The szilard hypothesis on the nature of aging
revisited.
Henrik Zetterberg, Magnus Båth, Madeleine Zetterberg, Peter Bernhardt, Ola Hammarsten
Genetics - 2009 -
Production of Rh-103m for cancer
therapy
Gunnar Skarnemark, Arvid Ödegaard-Jensen, J. Nilsson, B. Bartos, E. Kowalska, A. Bilewicz, Peter Bernhardt
Journal of Radioanalytical and Nuclear Chemistry - 2009 -
Potential of reducing normal tissue complications, using anti-angiogenic drugs in combination with radiotherapy-Modelling effects of improved tumor
oxygenation
Jakob Heydorn Lagerlöf, Peter Bernhardt
Society of Nuclear Medicine Annual Meeting Abstracts 2009 - 2009 -
Comparison of electron dose-point kernels in water generated by the Monte Carlo codes, PENELOPE, GEANT4, MCNPX, and
ETRAN.
Helena Uusijärvi, Nicolas Chouin, Peter Bernhardt, Ludovic Ferrer, Manuel Bardiès, Eva Forssell-Aronsson
Cancer biotherapy & radiopharmaceuticals - 2009 -
Quantitative analysis of tumor growth rate and changes in tumor marker level: specific growth rate versus doubling
time.
Esmaeil Mehrara, Eva Forssell-Aronsson, Håkan Ahlman, Peter Bernhardt
Acta oncologica (Stockholm, Sweden) - 2009 -
Tumour control probability (TCP) for non-uniform activity distribution in radionuclide
therapy.
Helena Uusijärvi, Peter Bernhardt, Eva Forssell-Aronsson
Physics in medicine and biology - 2008 -
Comparison of [177Lu-DOTA0,Tyr3]-octreotate and [177Lu-DOTA0,Tyr3]-octreotide for receptor-mediated radiation therapy of the xenografted human midgut carcinoid tumor
GOT1.
Christina Swärd, Peter Bernhardt, Viktor Johanson, Anneli Schmitt, Håkan Ahlman, Mats Stridsberg, Eva Forssell-Aronsson, Ola Nilsson, Lars Kölby
Cancer biotherapy & radiopharmaceuticals - 2008 -
Estimation of metastatic cure after radionuclide
therapy.
Peter Bernhardt, Eva Forssell-Aronsson
The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of Radiopharmaceutical Chemistry and Biology - 2007 -
A transplantable human medullary thyroid carcinoma as a model for RET tyrosine kinase-driven
tumorigenesis
Viktor Johanson, Håkan Ahlman, Peter Bernhardt, Svante Jansson, Lars Kölby, Fredrik Persson, Göran Stenman, Christina Swärd, Bo Wängberg, M. Stridsberg, Ola Nilsson
Endocrine-related cancer - 2007 -
Specific growth rate versus doubling time for quantitative characterization of tumor growth
rate.
Esmaeil Mehrara, Eva Forssell-Aronsson, Håkan Ahlman, Peter Bernhardt
Cancer research - 2007 -
Translation of dosimetric results of preclinical radionuclide therapy to clinical situations: influence of photon
irradiation.
Helena Uusijärvi, Peter Bernhardt, Eva Forssell-Aronsson
Cancer biotherapy & radiopharmaceuticals - 2007 -
Individual voxelwise dosimetry of targeted (90)Y-labelled substance P radiotherapy for malignant
gliomas.
Stefan Kneifel, Peter Bernhardt, Helena Uusijärvi, Stephan Good, Ludwig Plasswilm, Carlos Buitrago-Téllez, Jan Müller-Brand, Helmut Mäcke, Adrian Merlo
European journal of nuclear medicine and molecular imaging - 2007 -
Effects of treatment with (177)Lu-DOTA-Tyr(3)-octreotate on uptake of subsequent injection in carcinoid-bearing nude
mice.
Peter Bernhardt, Jenny Oddstig, Lars Kölby, Ola Nilsson, Håkan Ahlman, Eva Forssell-Aronsson
Cancer biotherapy & radiopharmaceuticals - 2007 -
Dosimetric characterization of radionuclides for systemic tumor therapy: influence of particle range, photon emission, and subcellular
distribution.
Helena Uusijärvi, Peter Bernhardt, Thomas Ericsson, Eva Forssell-Aronsson
Medical physics - 2006 -
Aspects on radionuclide therapy in malignant
pheochromocytomas.
Eva Forssell-Aronsson, Peter Bernhardt, Bo Wängberg, Lars Kölby, Ola Nilsson, Håkan Ahlman
Annals of the New York Academy of Sciences - 2006 -
Can quantification of VMAT and SSTR expression be helpful for planning radionuclide therapy of malignant
pheochromocytomas?
Lars Kölby, Peter Bernhardt, Viktor Johanson, Bo Wängberg, Andreas Muth, Svante Jansson, Eva Forssell-Aronsson, Ola Nilsson, Håkan Ahlman
Annals of the New York Academy of Sciences - 2006 -
Administered activity and metastatic cure probability during radioimmunotherapy of ovarian cancer in nude mice with 211At-MX35
F(ab')2.
Jörgen Elgqvist, Håkan Andersson, Peter Bernhardt, Tom Bäck, Ingela Claesson, Ragnar Hultborn, Holger Jensen, Bengt R Johansson, Sture Lindegren, Marita Olsson, Stig Palm, Elisabet Warnhammar Finnborg, Lars Jacobsson
International journal of radiation oncology, biology, physics - 2006 -
Radiation-induced up-regulation of somatostatin receptor expression in small cell lung cancer in
vitro.
Jenny Oddstig, Peter Bernhardt, Ola Nilsson, Håkan Ahlman, Eva Forssell-Aronsson
Nuclear medicine and biology - 2006 -
Electron- and positron-emitting radiolanthanides for therapy: aspects of dosimetry and
production.
Helena Uusijärvi, Peter Bernhardt, Frank Rösch, Helmut R Maecke, Eva Forssell-Aronsson
Journal of nuclear medicine : official publication, Society of Nuclear Medicine - 2006 -
Myelotoxicity and RBE of 211At-conjugated monoclonal antibodies compared with 99mTc-conjugated monoclonal antibodies and 60Co irradiation in nude
mice
Jörgen Elgqvist, Peter Bernhardt, Ragnar Hultborn, H. Jensen, Börje Karlsson, Sture Lindegren, Elisabet Warnhammar Finnborg, Lars Jacobsson
J Nucl Med - 2005 -
Antitumoural effects of the pyridyl cyanoguanidine CHS 828 on three different types of neuroendocrine tumours xenografted to nude
mice
Viktor Johanson, Yvonne Arvidsson, Lars Kölby, Peter Bernhardt, Christina Swärd, Ola Nilsson, Håkan Ahlman
Neuroendocrinology - 2005 -
Differences in biodistribution between 99mTc-depreotide, 111In-DTPA-octreotide, and 177Lu-DOTA-Tyr3-octreotate in a small cell lung cancer animal
model
Anneli Schmitt, Peter Bernhardt, Ola Nilsson, Håkan Ahlman, Lars Kölby, Eva Forssell-Aronsson
Cancer biotherapy & radiopharmaceuticals - 2005 -
Successful receptor-mediated radiation therapy of xenografted human midgut carcinoid
tumour
Lars Kölby, Peter Bernhardt, Viktor Johanson, Anneli Schmitt, Håkan Ahlman, Eva Forssell-Aronsson, H. Macke, Ola Nilsson
British journal of cancer - 2005 -
A novel photon radiation detector system for in vitro biokinetic
measurements.
Jenny Oddstig, Peter Bernhardt, Lars Jacobsson, Eva Forssell-Aronsson
Cancer biotherapy & radiopharmaceuticals - 2005 -
Modelling of metastatic cure after radionuclide therapy: influence of tumor distribution, cross-irradiation, and variable activity
concentration
Peter Bernhardt, Håkan Ahlman, Eva Forssell-Aronsson
Medical physics - 2004 -
Biodistribution data from 100 patients i.v. injected with
111In-DTPA-D-Phe1-octreotide
Eva Forssell-Aronsson, Peter Bernhardt, Ola Nilsson, Lars-Eric Tisell, Bo Wängberg, Håkan Ahlman
Acta oncologica (Stockholm, Sweden) - 2004 -
A comparison of In-111-DOTATOC and In-111-DOTATATE: biodistribution and dosimetry in the same patients with metastatic neuroendocrine
tumours
F. Forrer, Helena Uusijärvi, C. Waldherr, M. Cremonesi, Peter Bernhardt, J. Mueller-Brand, H.R. Maecke
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING - 2004 -
Radiation therapy of small cell lung cancer with 177Lu-DOTA-Tyr3-octreotate in an animal
model
Anneli Schmitt, Peter Bernhardt, Ola Nilsson, Håkan Ahlman, Lars Kölby, H. R. Maecke, Eva Forssell-Aronsson
Journal of nuclear medicine - 2004 -
Importance of vesicle proteins in the diagnosis and treatment of neuroendocrine
tumors.
Ola Nilsson, Anne-Marie Levin Jakobsen, Lars Kölby, Peter Bernhardt, Eva Forssell-Aronsson, Håkan Ahlman
Annals of the New York Academy of Sciences - 2004 -
GOT1 xenografted to nude mice: a unique model for in vivo studies on SSTR-mediated radiation therapy of carcinoid
tumors
Ola Nilsson, Lars Kölby, Peter Bernhardt, Eva Forssell-Aronsson, Viktor Johanson, Håkan Ahlman
Annals of the New York Academy of Sciences - 2004 -
Chromogranin A as a determinant of midgut carcinoid tumour
volume
Lars Kölby, Peter Bernhardt, Christina Swärd, Viktor Johanson, Håkan Ahlman, Eva Forssell-Aronsson, M. Stridsberg, Bo Wängberg, Ola Nilsson
Regulatory peptides - 2004 -
Uptake of meta-iodobenzylguanidine in neuroendocrine tumours is mediated by vesicular monoamine
transporters.
Lars Kölby, Peter Bernhardt, A-M Levin-Jakobsen, V Johanson, Bo Wängberg, Håkan Ahlman, Eva Forssell-Aronsson, Ola Nilsson
British journal of cancer - 2003 -
Model of metastatic growth valuable for radionuclide
therapy
Peter Bernhardt, Håkan Ahlman, Eva Forssell-Aronsson
Medical physics - 2003 -
Comparison of hematological toxicity of the alpha emitter 211At and the electron emitter 99mTc in nude
mice.
Jörgen Elgqvist, Peter Bernhardt, Ragnar Hultborn, Börje Karlsson, Sture Lindegren, Stig Palm, Lars Jacobsson
Cancer Biotherapy and Radiopharmaceuticals - 2002 -
A transplantable human carcinoid as model for somatostatin receptor-mediated and amine transporter-mediated radionuclide
uptake.
Lars Kölby, Peter Bernhardt, Håkan Ahlman, Bo Wängberg, V Johanson, A Wigander, Eva Forssell-Aronsson, S Karlsson, B Ahrén, G Stenman, Ola Nilsson
The American journal of pathology - 2001 -
111In-DTPA-D-Phe1-octreotide binding and somatostatin receptor subtypes in thyroid
tumors.
Eva Forssell-Aronsson, Ola Nilsson, S A Bejegård, Lars Kölby, Peter Bernhardt, Johan Mölne, S H Hashemi, Bo Wängberg, Lars-Eric Tisell, Håkan Ahlman
Journal of nuclear medicine : official publication, Society of Nuclear Medicine - 2000 -
Pharmacokinetics and dosimetry of radiolabelled octreotide for tumour
therapy
Peter Bernhardt
2000 -
Evaluation of three gamma detectors for intraoperative detection of tumors using 111In-labeled
radiopharmaceuticals.
S A Benjegård, V Sauret, Peter Bernhardt, Bo Wängberg, Håkan Ahlman, Eva Forssell-Aronsson
Journal of nuclear medicine : official publication, Society of Nuclear Medicine - 1999